CLIRINX LIMITED

CLIRINX Limited is a specialist IT provider for clinical‑research teams working on epilepsy and rare‑disease projects. By delivering a fully 21 CFR 11‑compliant, web‑based platform, CLIRINX enables researchers to design, run and close studies with confidence, while retaining complete ownership of their data. Their suite of tools covers every stage of the research lifecycle – from electronic data collection (EDC) and secure patient‑portal data sharing, to medical‑imaging adjudication workflows and a multilingual translation engine (cxText).

Beyond core study management, CLIRINX offers a Clinical Research ID (CRID) system, powerful data‑visualisation dashboards, and a Genetic Variant Tracker (VarTracker) that turn raw data into actionable insights. The platform also supports big‑data volumes, integrates external health‑informatics databases via APIs, and provides robust security features such as SSL encryption, two‑factor authentication, role‑based access and full audit trails, meeting both HIPAA and 21 CFR 11 standards.

The company’s expertise extends to patient registries, natural‑history studies and clinical‑trial‑readiness assessments, making CLIRINX the go‑to partner for academic centres, disease‑advocacy groups and pharmaceutical organisations seeking a reliable, end‑to‑end IT solution for rare‑disease research.